In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama- derived antibody fragments

HIGHLIGHTS

• who: Broadly Specific Recombinant Monovalent and collaborators from the Development Colworth House, Sharnbrook, United KingdomEditor: Karol Sestak, Tulane University, United States of America have published the paper: In Vitro Neutralisation of Rotavirus Infection by Two Broadly Specific Recombinant Monovalent Llama- Derived Antibody Fragments, in the Journal: (JOURNAL) of September/21,/2011
• what: The authors investigated the specificity and neutralising activity of two llama ARP1 and ARP3 against 13 cell culture adapted rotavirus strains of diverse genotypes.
• how: These results indicated that these molecules could potentially be used as immunoprophylactic and/or immunotherapeutic products . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.